Q12098 (Q12098): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
11,165,000.0 Czech koruna
| |||||||||||||||
| Property / EU contribution: 11,165,000.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
446,600.0 Euro
| |||||||||||||||
| Property / EU contribution: 446,600.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 446,600.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 446,600.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
22,330,000.0 Czech koruna
| |||||||||||||||
| Property / budget: 22,330,000.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
893,200.0 Euro
| |||||||||||||||
| Property / budget: 893,200.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 893,200.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 893,200.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 02:50, 12 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
11,165,000.0 Czech koruna
0 references
22,330,000.0 Czech koruna
0 references
50 percent
0 references
31 December 2020
0 references
EXBIO Praha, a.s.
0 references
49°59'0.49"N, 14°30'9.11"E
0 references
25250
0 references
Cílem projektu je zvýšení kapacit vlastního VaV společnosti EXBIO Praha, a.s. v oblasti stabilizovaných směsí fluorescenčně značených protilátek v jednotestovém balení pro průtokovou cytometrii. Rozšíření VIK posílí postavení společnosti na světovém obchodu s monoklonálními protilátkami, jejich deriváty a diagnostickými soupravami pro klinickou diagnostiku ve zdravotnictví a umožní další rozšíření a diversifikaci produktů především do zdravotnické diagnostiky. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_165/0015522
0 references